γ-Linolenic acid versus α-lipoic acid for treating painful diabetic neuropathy in adults: A 12-week, double-placebo, randomized, noninferiority trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Won J.C. | - |
dc.contributor.author | Kwon H.-S. | - |
dc.contributor.author | Moon S.-S. | - |
dc.contributor.author | Chun S.W. | - |
dc.contributor.author | Kim C.H. | - |
dc.contributor.author | Park I.B. | - |
dc.contributor.author | Kim I.J. | - |
dc.contributor.author | Lee J. | - |
dc.contributor.author | Cha B.Y. | - |
dc.contributor.author | Park T.S. | - |
dc.date.available | 2020-07-02T07:35:25Z | - |
dc.date.created | 2020-04-28 | - |
dc.date.issued | 2020-08 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/60269 | - |
dc.description.abstract | Background: This study was a multicenter, parallel-group, double-blind, double-dummy, randomized, noninferiority trial to evaluate the efficacy and safety of γ-linolenic acid (GLA) relative to α-lipoic acid (ALA) over a 12-week treatment period in type 2 diabetes mellitus (T2DM) patients with painful diabetic peripheral neuropathy (DPN). Methods: This study included 100 T2DM patients between 20 and 75 years of age who had painful DPN and received either GLA (320 mg/day) and placebo or ALA (600 mg/day) and placebo for 12 weeks. The primary outcome measures were mean changes in pain intensities as measured by the visual analogue scale (VAS) and the total symptom scores (TSS). Results: Of the 100 subjects who initially participated in the study, 73 completed the 12-week treatment period. Per-protocol analyses revealed significant decreases in the mean VAS and TSS scores compared to baseline in both groups, but there were no significant differences between the groups. The treatment difference for the VAS (95% confidence interval [CI]) between the two groups was -0.65 (-1.526 to 0.213) and the upper bound of the 95% CI did not exceed the predefined noninferiority margin (δ1=0.51). For the TSS, the treatment difference was -0.05 (-1.211 to 1.101) but the upper bound of the 95% CI crossed the non-inferiority margin (δ2=0.054). There were no serious adverse events associated with the treatments. Conclusion: GLA treatment in patients with painful DPN was noninferior to ALA in terms of reducing pain intensity measured by the VAS over 12 weeks. Copyright © 2019 Korean Diabetes Association. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Diabetes Association | - |
dc.relation.isPartOf | Diabetes and Metabolism Journal | - |
dc.title | γ-Linolenic acid versus α-lipoic acid for treating painful diabetic neuropathy in adults: A 12-week, double-placebo, randomized, noninferiority trial | - |
dc.title.alternative | γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000564145900006 | - |
dc.identifier.doi | 10.4093/dmj.2019.0099 | - |
dc.identifier.bibliographicCitation | Diabetes and Metabolism Journal, v.44, no.4, pp.542 - 554 | - |
dc.identifier.kciid | ART002616267 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85083514952 | - |
dc.citation.endPage | 554 | - |
dc.citation.startPage | 542 | - |
dc.citation.title | Diabetes and Metabolism Journal | - |
dc.citation.volume | 44 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Park I.B. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Diabetic neuropathies | - |
dc.subject.keywordAuthor | Gamma-linolenic acid | - |
dc.subject.keywordAuthor | Thioctic acid | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.